Screening of benzamidine-based thrombin inhibitors via a linear interaction energy in continuum electrostatics model

scientific article

Screening of benzamidine-based thrombin inhibitors via a linear interaction energy in continuum electrostatics model is …
instance of (P31):
scholarly articleQ13442814

External links are
P8978DBLP publication IDjournals/jcamd/NicolottiGMCLPC10
P356DOI10.1007/S10822-010-9320-1
P8608Fatcat IDrelease_sxmel6ysubhc5erpfsi3exswqy
P698PubMed publication ID20148287
P5875ResearchGate publication ID41422698

P50authorOrazio NicolottiQ42702402
Ilenia GiangrecoQ47157749
Francesco LeonettiQ54936343
Leonardo PisaniQ56944044
Angelo CarottiQ64857534
P2093author name stringMarino Convertino
Teresa Fabiola Miscioscia
P2860cites workThe Protein Data BankQ24515306
A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active siteQ27631070
Factorising ligand affinity: a combined thermodynamic and crystallographic study of trypsin and thrombin inhibitionQ27635537
Structure-based design of novel potent nonpeptide thrombin inhibitorsQ27638874
Crystal structure of human alpha-thrombin complexed with hirugen and p-amidinophenylpyruvate at 1.6 A resolutionQ27729702
Development and validation of a genetic algorithm for flexible dockingQ28236574
Similarity-based virtual screening using 2D fingerprintsQ28275838
Comparison of consensus scoring strategies for evaluating computational models of protein-ligand complexesQ28292827
A critical assessment of docking programs and scoring functionsQ29616761
Benchmarking sets for molecular dockingQ29619637
A new test set for validating predictions of protein-ligand interaction.Q30332170
Comparison between Generalized-Born and Poisson-Boltzmann methods in physics-based scoring functions for protein structure prediction.Q30351224
A computational procedure for determining energetically favorable binding sites on biologically important macromoleculesQ30406755
Comprehensive assessment of automatic structural alignment against a manual standard, the scop classification of proteinsQ30430015
What do we know and when do we know it?Q30481529
Simulated molecular evolution in a full combinatorial libraryQ30883172
Evaluation of docking performance: comparative data on docking algorithmsQ30889483
Computational modelling of inhibitor binding to human thrombinQ30982674
Screening of matrix metalloproteinases available from the protein data bank: insights into biological functions, domain organization, and zinc binding groupsQ31134150
Efficient evaluation of binding free energy using continuum electrostatics solvationQ33208396
Discovery of kinase inhibitors by high-throughput docking and scoring based on a transferable linear interaction energy modelQ33319604
Investigation of MM-PBSA rescoring of docking posesQ33332674
Library screening by fragment-based dockingQ33498543
Further development and validation of empirical scoring functions for structure-based binding affinity predictionQ34526566
Drugs, their targets and the nature and number of drug targetsQ34571023
MM-GB/SA rescoring of docking poses in structure-based lead optimization.Q34771348
Pharmacophore discovery--lessons learnedQ35181134
Prediction of protein-ligand interactions. Docking and scoring: successes and gapsQ36605327
Free energy via molecular simulation: applications to chemical and biomolecular systemsQ38648060
The properties of known drugs. 1. Molecular frameworksQ40933327
Consensus scoring for ligand/protein interactionsQ42670601
Is quantum mechanics necessary for predicting binding free energy?Q42979436
Improving quantitative structure-activity relationships through multiobjective optimizationQ43270292
Compass: predicting biological activities from molecular surface properties. Performance comparisons on a steroid benchmarkQ46045402
An integrated approach to ligand- and structure-based drug design: development and application to a series of serine protease inhibitorsQ46550563
Alpha7 nicotinic acetylcholine receptor agonists: prediction of their binding affinity through a molecular mechanics Poisson-Boltzmann surface area approachQ46597035
A simple protocol to estimate differences in protein binding affinity for enantiomers without prior resolution of racematesQ46865759
Evaluation of binary QSAR models derived from LUDI and MOE scoring functions for structure based virtual screening.Q46903422
Consensus adaptation of fields for molecular comparison (AFMoC) models incorporate ligand and receptor conformational variability into tailor-made scoring functionsQ46933916
Assessing scoring functions for protein-ligand interactionsQ47429905
Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteinsQ47746759
Computational approaches to molecular recognition.Q47829750
QSAR and QSPR studies of a highly structured physicochemical domain.Q51955502
Estimation of binding free energies for HIV proteinase inhibitors by molecular dynamics simulations.Q52324255
Multipolar interactions in the D pocket of thrombin: large differences between tricyclic imide and lactam inhibitorsQ62032123
Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithromboticsQ68034781
A new method for predicting binding affinity in computer-aided drug designQ72408636
Calculation of the electric potential in the active site cleft due to alpha-helix dipolesQ72952190
Properties of known drugs. 2. Side chainsQ73284123
Binding affinities for sulfonamide inhibitors with human thrombin using Monte Carlo simulations with a linear response methodQ73346494
Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin,Q78162558
Comparative binding energy analysis considering multiple receptors: a step toward 3D-QSAR models for multiple targetsQ79223325
Modeling ligand-receptor interaction for some MHC class II HLA-DR4 peptide mimetic inhibitors using several molecular docking and 3D QSAR techniquesQ81253747
Improving Docking Accuracy through Molecular Mechanics Generalized Born Optimization and ScoringQ86841260
P433issue2
P304page(s)117-129
P577publication date2010-02-11
P1433published inJournal of Computer - Aided Molecular DesignQ15766522
P1476titleScreening of benzamidine-based thrombin inhibitors via a linear interaction energy in continuum electrostatics model
P478volume24

Reverse relations

Q54428367Ligand-enabled multiple absolute stereocontrol in metal-catalysed cycloaddition for construction of contiguous all-carbon quaternary stereocentres.cites workP2860

Search more.